The Province is providing $195M in funding in life sciences
Darpan News Desk The Canadian Press, 02 Mar, 2022 05:03 PM
The province is providing 195-million dollars in grant funding to help attract and retain top researchers in the life sciences field.
Jobs Minister Ravi Kahlon says Michael Smith Health Research B-C will get 116-million dollars while Genome BC will get the rest in order to spur innovation.
— Brenda Bailey, MLA (@BrendaBaileyBC) March 2, 2022
Kahlon says the province wants to leverage B-C's contributions to developing and manufacturing COVID-19 vaccines towards learning how to deal with future pandemics.
He says the funding could also help advance research in a range of areas including the development of new medications, rapid diagnostic tests for diseases and clean technology.Â
In a brief released today, the Ontario COVID-19 Science Advisory Table says the symptoms of so-called long COVID can last from weeks to months after contracting the virus.
Â
Â
There are no concerns for public safety at this time. The motive for these shootings and whether there is a nexus to the Lowermainland gang conflict are still under investigation.
Dr.Henry says about 15,000 British Columbians who are severely immunocompromised will receive a third dose in accordance with guidance from the National Advisory Committee on Immunization. They include those who've received an organ, bone marrow or stem cell transplant.
 85.8% (3,978,624) of eligible people 12 and older in B.C. have received their first dose of COVID-19 vaccine and 78.4% (3,632,547) received their second dose.
The former MP for Kitchener Centre stepped down after facing allegations that he harassed a female staff member, claims he firmly denies. Saini is entitled to a $92,900 severance cheque, worth half his $185,800 MP's salary.
Finance Minister Selina Robinson says the province's financial statement for the first three months of the 2021-22 fiscal year projects a deficit of $4.8 billion, about half the $9.7 billion that was originally forecast in the budget.
Â
Â
